# Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression

> **NCT07664852** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Daniel Lindqvist** · enrollment: 126 (estimated)

## Conditions studied

- Bipolar Disorder (BD)

## Interventions

- **DRUG:** Pramipexole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07664852
- **Lead sponsor:** Daniel Lindqvist
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07664852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07664852, "Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07664852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*